138 related articles for article (PubMed ID: 8978299)
1. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
[TBL] [Abstract][Full Text] [Related]
2. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
[TBL] [Abstract][Full Text] [Related]
5. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
[TBL] [Abstract][Full Text] [Related]
6. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
[TBL] [Abstract][Full Text] [Related]
7. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G
Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes.
Zambello R; Trentin L; Facco M; Cerutti A; Sancetta R; Milani A; Raimondi R; Tassinari C; Agostini C; Semenzato G
Cancer Res; 1995 Dec; 55(24):6140-5. PubMed ID: 8521405
[TBL] [Abstract][Full Text] [Related]
10. Large granular lymphocytosis.
Zambello R; Semenzato G
Haematologica; 1998 Oct; 83(10):936-42. PubMed ID: 9830801
[TBL] [Abstract][Full Text] [Related]
11. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.
Pandolfi F; Foa R; De Rossi G; Zambello R; Chisesi T; di Celle PF; Migone N; Casorati G; Scarselli E; Ensoli F
Clin Immunol Immunopathol; 1991 Sep; 60(3):371-83. PubMed ID: 1830831
[TBL] [Abstract][Full Text] [Related]
12. Clonal diseases of large granular lymphocytes.
Loughran TP
Blood; 1993 Jul; 82(1):1-14. PubMed ID: 8324214
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal abnormalities define clonal proliferation in CD3- large granular lymphocyte leukemia.
Taniwaki M; Tagawa S; Nishigaki H; Horiike S; Misawa S; Shimazaki C; Maekawa T; Fujii H; Kitani T; Abe T
Am J Hematol; 1990 Jan; 33(1):32-8. PubMed ID: 2152842
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study.
Pandolfi F; Loughran TP; Starkebaum G; Chisesi T; Barbui T; Chan WC; Brouet JC; De Rossi G; McKenna RW; Salsano F
Cancer; 1990 Jan; 65(2):341-8. PubMed ID: 2403836
[TBL] [Abstract][Full Text] [Related]
16. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.
Nash R; McSweeney P; Zambello R; Semenzato G; Loughran TP
Blood; 1993 May; 81(9):2363-8. PubMed ID: 8097633
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes.
Makishima H; Ishida F; Saito H; Ichikawa N; Ozaki Y; Ito S; Ota M; Katsuyama Y; Kiyosawa K
Eur J Haematol; 2003 Apr; 70(4):212-8. PubMed ID: 12656743
[TBL] [Abstract][Full Text] [Related]
18. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes.
Zambello R; Loughran TP; Trentin L; Pontisso P; Battistella L; Raimondi R; Facco M; Sancetta R; Agostini C; Pizzolo G
Leukemia; 1995 Jul; 9(7):1207-11. PubMed ID: 7630196
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD55 and CD59 on peripheral blood cells in patients with lymphoproliferative disease of granular lymphocytes.
Isoda A; Tsukamoto N; Mitsui T; Yamane A; Hatsumi N; Matsushima T; Murakami H; Nojima Y; Karasawa M
Int J Lab Hematol; 2007 Feb; 29(1):52-7. PubMed ID: 17224008
[TBL] [Abstract][Full Text] [Related]
20. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
Hoshino S; Oshimi K; Teramura M; Mizoguchi H
Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
